Your browser doesn't support javascript.
loading
BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis.
Ny, L; Hernberg, M; Nyakas, M; Koivunen, J; Oddershede, L; Yoon, M; Wang, X; Guyot, P; Geisler, J.
Afiliación
  • Ny L; Department of Oncology, Institute of Clinical Science, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Hernberg M; Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
  • Nyakas M; Oslo University Hospital, Oslo, Norway.
  • Koivunen J; Department of Oncology and Radiotherapy, Oulu University Hospital, MRC Oulu, Oulu, Finland.
  • Oddershede L; Novartis Healthcare A/S, Copenhagen, Denmark.
  • Yoon M; Novartis Healthcare A/S, Copenhagen, Denmark.
  • Wang X; Commercialization & Outcomes, ICON plc, Stockholm, Sweden.
  • Guyot P; Commercialization & Outcomes, ICON plc, Lyon, France.
  • Geisler J; Institute of Clinical Medicine, Campus AHUS, University of Oslo, Oslo, Norway.
Acta Oncol ; 59(7): 833-844, 2020 Jul.
Article en En | MEDLINE | ID: mdl-32285732
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Proteínas Proto-Oncogénicas B-raf / Melanoma Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Acta Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Proteínas Proto-Oncogénicas B-raf / Melanoma Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Acta Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Suecia